New Delhi [India], January 1 (ANI) In a major development related to the COVID vaccine, the Subject Expert Committee of Drugs Controller General of India (DCGI) has recommended granting permission for Emergency Use Authorisation (EUA)with certain conditions to COVID-19 vaccine being manufact
New Delhi [India], December 31 (ANI/PRSpot): Living through the COVID-19 pandemic in the past 9 months, people have been forced to look after their health and personal hygiene. As these become the priority for most Indians, sales of the facial skincare brands have gained momentum as well. Mo
New Delhi [India], December 30 (ANI): Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a "big step forward", AIIMS Delhi Director Dr Randeep Guleria on Wednesday said that India will have the COVID-19 vaccine within days.
New Delhi [India], December 30 (ANI): Subject Expert Committee (SEC) of Drugs Controller of India will take a meeting to consider Serum Institute of India's application for emergency use approval of its COVID-19 vaccine, says a government official.
New Delhi [India], December 29 (ANI): Union Health Minister Dr Harsh Vardhan On Monday inaugurated India's first pneumococcal conjugate vaccine "Pneumosil", which has been developed by the Serum Institute of India Private Limited (SIIPL) in collaboration with partners like the Bill and Melin
Pune (Maharashtra) [India], December 28 (ANI): Serum Institute of India, the largest vaccine manufacturer in the world by doses, announces the launch of India's first indigenously developed pneumococcal vaccine - PNEUMOSIL.
New Delhi [India], December 28 (ANI): Union Health Minister Harsh Vardhan Monday inaugurated India's first Pneumococcal Conjugate Vaccine (PCV) in a bid to prevent about 67,800 child mortality under 5 years of age in India from pneumococcal diseases every year.
Pune (Maharashtra) [India], December 28 (ANI): In what could be termed as New Year gift, Adar Poonawalla, Chief Executive Officer, Serum Institute of India on Monday said 40-50 million doses of COVID-19 vaccine have already been stockpiled, adding that Covishield rollout is expected in Ja
New Delhi[India], December 9 (ANI): In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines
New Delhi [India], December 9 (ANI): The Ministry of Health and Family Welfare on Wednesday dismissed the media report about the rejection of Serum Institute India (SII) and Bharat Biotech's emergency use authorisation of COVID vaccine and called it "fake".
New Delhi [India], December 7 (ANI): Delhi Lieutenant Governor Anil Baijal on Monday chaired a meeting with Principal Secretary (Health) and Directorate General of Health Services (DGHS) and additional director of Serum Institute of India (SII) to review preparedness for COVID-19 vaccination
New Delhi [India], December 7 (ANI): Bharat Biotech on Monday applied for emergency use authorisation for its indigenously developed COVID-19 vaccine 'Covaxin' to Drugs Controller General of India (DCGI), officials said.